Mergers & Acquisitions - Eddingpharm

Filter

Current filters:

Eddingpharm

Popular Filters

176 to 200 of 843 results

BTG ups full year guidance following acquisitions

03-10-2013

UK specialist health care company BTG has provided an update for the six months ended September 30, 2013,…

BTGFinancialMergers & AcquisitionsPharmaceutical

Astex urges stockholders to tender shares into Otsuka offer

03-10-2013

The board of directors of USA-based Astex Pharmaceuticalsissued a letter to stockholders addressing what…

Astex PharmaceuticalsMergers & AcquisitionsOtsukaPharmaceutical

GlaxoSmithKline agrees £700 million deal with Aspen

GlaxoSmithKline agrees £700 million deal with Aspen

30-09-2013

GlaxoSmithKline says it has now reached agreement to sell its thrombosis brands, Arixtra and Fraxiparine,…

ArixtraAspen PharmacareCardio-vascularFraxiparineGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalRest of the World

US FTC calls for divestments for Mylan acquisition of Agila Specialties to proceed

US FTC calls for divestments for Mylan acquisition of Agila Specialties to proceed

27-09-2013

The USA’s Federal Trade Commission will require Mylan and Agila Specialties to divest 11 generic injectable…

Agila SpecialitesGenericsMergers & AcquisitionsMylan LaboratoriesNorth AmericaStrides Arcolab

France’s Servier offers to take full control of Egis Pharma

France’s Servier offers to take full control of Egis Pharma

25-09-2013

French privately-held drugmaker Servier has made a voluntary public offer to buy all outstanding shares…

EGIS PharmaceuticalsEuropeMergers & AcquisitionsPharmaceuticalServier

Retrophin ups unsolicited offer to buy Transcept Pharma shares not already owned

Retrophin ups unsolicited offer to buy Transcept Pharma shares not already owned

20-09-2013

USA-based Retrophin (OTCQB: RTRX) has made a proposal to the board of directors of Transcept Pharmaceuticals…

Mergers & AcquisitionsPharmaceuticalRetrophinTranscept Pharma

First-half 2013 sees fall in licensing, says Evaluate

20-09-2013

Despite a positive start to the year characterized by healthy initial public offering (IPO) activity…

FinancialLicensingMergers & AcquisitionsPharmaceutical

Hikma sets up JV for entering Ethiopian pharma market

Hikma sets up JV for entering Ethiopian pharma market

18-09-2013

Jordon-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says that it has signed a 50:50 joint…

GenericsHikma PharmaceuticalsMarkets & MarketingMergers & AcquisitionsMIDROC PharmaceuticalsRest of the World

UK's BTG sells brachytherapy business for $5million

UK's BTG sells brachytherapy business for $5million

17-09-2013

UK-based specialty pharma company BTG (LSE: BTG) has sold its brachytherapy business to German company…

BTGEuropeMergers & AcquisitionsPharmaceutical

Chiesi Farmaceutici to acquire full ownership of Cornerstone Therapeutics

17-09-2013

Privately-held Italian drugmaker Chiesi Farmaceutici and specialty US firm Cornerstone Therapeutics (Nasdaq:…

Chiesi FarmaceuticiCornerstone TherapeuticsMergers & AcquisitionsPharmaceutical

Adcock Ingram agrees takeover terms with CFR

12-09-2013

Adcock Ingram (AIP: SP), one of South Africa's largest drugmakers, has provided further details of the…

Adcock IngramCFR PharmaceuticalsGenericsMergers & AcquisitionsPharmaceutical

Cellceutix acquires PolyMedix assets from bankruptcy court

09-09-2013

US clinical-stage biopharma firm Cellceutix (OTCBB: CTIX) has acquired substantially all of the assets…

BiotechnologybrilacidinCellceutixMergers & AcquisitionsPharmaceuticalPolyMedixPrurisol

Italy's Recordati to acquire Spanish drugmaker

09-09-2013

In a second takeover deal this year, Italian drugmaker Recordati (RC: MI) says it has signed agreements…

CitrafleetGastro-intestinalsLab Casen FleetMergers & AcquisitionsPharmaceuticalRecordatiWomen's Health

bioMerieux makes significant US acquisition in molecular biology

05-09-2013

French in vitro diagnostics firm bioMerieux (Euronext: BIM) has entered into an agreement to acquire…

BioFire DiagnosticsBioMerieuxMergers & AcquisitionsPharmaceutical

Otsuka confirms takeover bid for Astex Pharmaceuticals for $886 million

05-09-2013

Following heavy speculation on Wednesday (see The Pharma Letter story earlier today), this morning Japanese…

Astex PharmaceuticalsBiotechnologyMergers & AcquisitionsOncologyOtsukaPharmaceutical

Otsuka said to be buying Astex Pharma

05-09-2013

Japanese mid-size drugmaker Otsuka (TYO: 4768) is planning to acquire USA-based Astex Pharmaceuticals…

Astex PharmaceuticalsBiotechnologyMergers & AcquisitionsOncologyOtsukaPharmaceutical

Russian billionaire to acquire control of Veropharm

03-09-2013

Roman Avdeev, a well-known Russian banker and one of the country's richest people, has agreed to acquire…

GenericsMergers & AcquisitionsPharmaceuticalVeropharm

Meda acquires US respiratory company

02-09-2013

Swedish drugmaker Meda (STO:MEDAA) has signed an agreement to acquire the US development company Acton…

Acton PharmaceuticalsAerospan HFAFlunisolideMedaMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Endo Health expends $225 million on generic acquisition

29-08-2013

USA-based specialty health care company Endo Health Solutions (Nasdaq: ENDP) says that that its Qualitest…

Boca PharmacalEndo Health SolutionsGenericsMergers & AcquisitionsPharmaceutical

Sangamo BioSciences to buy Ceregene

28-08-2013

In its first takeover bid since 2001, US drugmaker Sangamo BioSciences (Nasdaq: SGMO) has signed a definitive…

BiotechnologyCERE-110CeregeneMergers & AcquisitionsNeurologicalOphthalmicsSangamo BioSciences

Akorn buys rival generic drugmaker for $640 million

27-08-2013

USA-based generics drugmaker Akorn (Nasdaq: AKRX) has bought rival generic drugmaker Hi-Tech Pharmacal…

AkornGenericsHi-Tech PharmacalMergers & AcquisitionsNorth America

Immune Pharma and EpiCept complete merger

27-08-2013

Israel-based Immune Pharmaceuticals (Nasdaq OMX Stockholm Exchange: IMNP) says it has now completed its…

AmiKetEpiCeptImmune PharmaceuticalsMergers & AcquisitionsPharmaceutical

Onyx Pharma accepts increased bid from Amgen

27-08-2013

Amgen (Nasdaq: AMGN), the world largest independent biotech group, said on Sunday (August 25) that the…

AmgenBayerBiotechnologyKyprolisMergers & AcquisitionsOncologyOnyx PharmaceuticalsPfizer

176 to 200 of 843 results

Company Spotlight

Fibrotech

Fibrotech

Back to top